Synlett 2012; 23(15): 2215-2218
DOI: 10.1055/s-0032-1317075
letter
© Georg Thieme Verlag Stuttgart · New York

Copper-Catalyzed One-Pot Synthesis of Functionalized 1,4-Dihydroazete Derivatives from Sulfonyl Azides, Terminal Alkynes, and Tetramethylguanidine

Issa Yavari*
Department of Chemistry, Tarbiat Modares University, PO Box 14115-175, Tehran, Iran, Fax: +98(21)82883455   Email: yavarisa@modares.ac.ir
,
Manijeh Nematpour
Department of Chemistry, Tarbiat Modares University, PO Box 14115-175, Tehran, Iran, Fax: +98(21)82883455   Email: yavarisa@modares.ac.ir
› Author Affiliations
Further Information

Publication History

Received: 20 May 2012

Accepted after revision: 18 July 2012

Publication Date:
17 August 2012 (online)


Abstract

Ketenimine intermediates generated by the addition of copper acetylides to sulfonyl azides are trapped by tetramethyl­guanidine to afford 1,4-dihydro-N,N-dimethyl-3-aryl(alkyl)-4-­aryl(alkyl)sulfoniminoazet-2-amine derivatives in moderate to good yields.

 
  • References and Notes

  • 1 Alcaide B, Almendros P In Progress in Heterocyclic Chemistry . Vol. 17. Gribble GW, Joule JA. Elsevier; Oxford: 2005: 64-83
  • 2 Parrick J, Mehta LK In Comprehensive Heterocyclic Chemistry II . Padwa A. Elsevier; Oxford: 1996: 659-720
  • 3 Pinder AR. Nat. Prod. Rep. 1992; 9: 491
  • 4 Furin GG, Lopyrev VA, Zhuzhgov EI, Protsuk NI. Russ. J. Org. Chem. 2000; 36: 99
  • 5 Zanatta N, Barichello R, Bonacorso HG, Martins MA. P. Synthesis 1999; 765
  • 6 Yoakim C, Ogilvie WW, Cameron DR, Chabot C, Guse I, Hache B, Naud J, O’Meara JA, Plante R, Deziel R. J. Med. Chem. 1998; 41: 2882
  • 7 Kvaerno L, Werder M, Hauser H, Carreira EM. J. Med. Chem. 2005; 48: 6035
  • 8 Bisacchi GS, Slusarchyk WA, Bolton SA, Hartl KS, Jacobs G, Mathur A, Meng W, Ogletree ML, Pi Z, Sutton JC, Treuner U, Zahler R, Zhao G, Seiler SM. Bioorg. Med. Chem. Lett. 2004; 14: 2227
  • 9 Ma Y, Qian CT. Tetrahedron Lett. 2000; 41: 945
  • 10 Burtosolo AC. B, Correa CR. D. Tetrahedron Lett. 2006; 47: 6377
  • 11 George L, Bernhardt PV, Netsch KP, Wentrup C. Org. Biomol. Chem. 2004; 2: 3518
  • 12 Finnerty JJ, Wentrup C. J. Org. Chem. 2004; 69: 1909
  • 13 Wang J, Wang J, Zhu Y, Lu P, Wang Y. Chem. Commun. 2011; 47: 3275
  • 14 Whiting M, Fokin VV. Angew. Chem. Int. Ed. 2006; 45: 3157
  • 15 Xu X, Cheng D, Li J, Guo H, Yan J. Org. Lett. 2007; 9: 1585
  • 16 Cui SL, Lin XF, Wang YG. Org. Lett. 2006; 8: 4517
  • 17 Cui SL, Wang J, Wang YG. Tetrahedron 2008; 64: 487
  • 18 Yao W, Pan L, Zhang Y, Wang G, Wang X, Ma C. Angew. Chem. Int. Ed. 2010; 49: 9210
  • 19 Yavari I, Nematpour M, Yavari S, Sadeghizadeh F. Tetrahedron Lett. 2012; 53: 1889
  • 20 Yavari I, Nematpour M, Ghazanfarpour-Darjani M. Tetrahedron Lett. 2012; 53: 942
  • 21 General Procedure for the Synthesis of Compounds 4
    To a mixture of sulfonyl azide 2, (1.2 mmol), alkyne 1 (1 mmol), and CuI (0.1 mmol), Et3N (1 mmol) in THF (2 mL) was slowly added tetramethylguanidine (1 mmol). The mixture was stirred at r.t. After completion of the reaction [about 12 h; TLC (EtOAc–hexane = 1:5) monitoring], the mixture was diluted with CH2Cl2 (2 mL) and aq NH4Cl solution (3 mL), stirred for 30 min, and the layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 3 mL), and the combined organic fractions were dried (Na2SO4) and concentrated under reduced pressure. The residue was purified by flash column chromatography [silica gel (230–400 mesh; Merck), hexane–EtOAc = 5:1] to give the product. 1,4-Dihydro-N,N-dimethyl-3-phenyl-4-tosyliminoazet-2-amine (4a) Yellow oil; yield 0.27 g (80%). IR (KBr): νmax = 3438, 2923, 1511, 1396, 1270, 1139, 1083 cm–1. 1H NMR (500 MHz, CDCl3): δ = 2.38 (3 H, s, Me), 2.80 (6 H, s, NMe2), 3.94 (1 H, s, NH), 7.18 (2 H, t, 3 J = 7.5 Hz, Ar), 7.24 (1 H, t, 3 J = 7.5 Hz, Ar), 7.25–7.28 (4 H, m, Ph), 7.76 (2 H, d, 3 J = 7.9 Hz, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 29.7 (Me), 40.5 (NMe2), 88.3 (C), 125.7 (CH), 126.4 (2 CH), 128.1 (2 CH), 128.7 (2 CH), 129.6 (2 CH), 137.5 (C), 141.1 (C), 142.3 (C), 166.1 (C), 169.2 (C). MS (EI): m/z (%) = 341 (2) [M+], 297 (8), 271 (12), 155 (100), 145 (22), 91 (70), 77 (54). Anal. Calcd (%) for C18H19N3O2S (341.00): C, 63.32; H, 5.61; N, 12.31. Found: C, 63.79; H, 5.54; N, 12.38. 1,4-Dihydro-N,N-dimethyl-3-phenyl-4-benzenesulfoniminoazet-2-amine (4b) Yellow oil; yield 0.27 g (82%). IR (KBr): νmax = 3437, 2929, 1520, 1400, 1273, 1142, 1087 cm–1. 1H NMR (500 MHz, CDCl3): δ = 2.85 (6 H, s, NMe2), 3.98 (1 H, s, NH), 7.15 (2 H, t, 3 J = 7.5 Hz, Ar), 7.20 (1 H, t, 3 J = 7.5 Hz, Ar), 7.23 (2 H, d, 3 J = 7.5 Hz, Ar), 7.25–7.29 (3 H, m, Ph), 7.78 (2 H, d, 3 J = 7.9 Hz, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 40.6 (NMe2), 88.5 (C), 125.6 (CH), 126.5 (2 CH), 128.3 (2 CH), 128.8 (2 CH), 129.7 (2 CH), 137.5 (CH), 140.2 (C), 142.5 (C), 165.7 (C), 170.8 (C). MS (EI): m/z (%) = 327 (3) [M+], 283 (12), 257 (17), 145 (31), 141 (100), 77 (54). Anal. Calcd (%) for C17H17N3O2S (327.05): C, 62.36; H, 5.23; N, 12.83. Found: C, 62.06; H, 5.18; N, 12.75. 1,4-Dihydro-N,N-dimethyl-3-phenyl-4-methanesulfoniminoazet-2-amine (4c) Yellow oil; yield 0.20 g (74%). IR (KBr): νmax = 3435, 2925, 1531, 1401, 1271, 1120 cm–1. 1H NMR (500 MHz, CDCl3): δ = 2.81 (3 H, s, Me), 2.93 (6 H, s, NMe2), 4.01 (1 H, s, NH), 7.26 (2 H, t, 3 J = 7.4 Hz, Ar), 7.30 (1 H, t, 3 J = 7.4 Hz, Ar), 7.42 (2 H, d, 3 J = 7.4 Hz, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 29.2 (Me), 40.4 (NMe2), 87.2 (C), 124.4 (CH), 125.7 (2 CH), 126.4 (2 CH), 140.9 (C), 162.3 (C), 172.5 (C). MS (EI): m/z (%) = 265 (2) [M+], 221 (10), 195 (14), 145 (30), 79 (100), 77 (44). Anal. Calcd (%) for C12H15N3O2S (265.00): C, 54.32; H, 5.70; N, 15.06. Found: C, 54.66; H, 5.64; N, 15.16. 1,4-Dihydro-N,N-dimethyl-3-propyl-4-tosyliminoazet-2-amine (4d) Yellow oil; yield 0.20 g (67%). IR (KBr): νmax = 3436, 2924, 1510, 1397, 1271, 1138, 1084 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.87 (3 H, t, 3 J = 6.9 Hz, Me), 1.57–1.62 (2 H, m, CH2), 2.38 (3 H, s, Me), 2.52 (2 H, t, 3 J = 7.0 Hz, CH2), 2.91 (6 H, s, NMe2), 3.94 (1 H, s, NH), 7.24 (2 H, d, 3 J = 8.0 Hz, Ar), 7.81 (2 H, d, 3 J = 8.0 Hz, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 13.8 (Me), 21.4 (CH2), 22.7 (CH2), 29.7 (Me), 40.5 (NMe2), 86.1 (C), 126.5 (2 CH), 128.4 (2 CH), 139.0 (C), 142.0 (C), 166.6 (C), 172.5 (C). MS (EI): m/z (%) = 307 (2) [M+], 263 (14), 197 (14), 155 (100), 111 (28), 91 (55), 77 (44), 43 (22). Anal. Calcd (%) for C15H21N3O2S (307.01): C, 58.61; H, 6.89; N, 13.67. Found: C, 58.89; H, 6.94; N, 13.54. 1,4-Dihydro-N,N-dimethyl-3-propyl-4-benzenesulfoniminoazet-2-amine (4e) Yellow oil; yield 0.17 g (60%). IR (KBr): νmax = 3455, 2925, 1513, 1269, 1142, 1087 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.87 (3 H, t, 3 J = 7.0 Hz, Me), 1.57–1.60 (2 H, m, CH2), 2.51 (2 H, t, 3 J = 7.0 Hz, CH2), 2.89 (6 H, s, NMe2), 3.93 (1 H, s, NH), 7.39 (1 H, t, 3 J = 8.0 Hz, Ar), 7.43 (2 H, t, 3 J = 8.0 Hz, Ar), 7.91 (2 H, d, 3 J = 8.0 Hz, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 13.9 (Me), 21.1 (CH2), 22.8 (CH2), 40.5 (NMe2), 86.1 (C), 124.3 (CH), 125.6 (2 CH), 128.2 (2 CH), 135.7 (C), 162.9 (C), 172.4 (C). MS (EI): m/z (%) = 293 (3) [M+], 249 (13), 223 (8), 141 (100), 111 (18), 77 (34), 43 (35). Anal. Calcd (%) for C14H19N3O2S (293.00): C, 57.31; H, 6.53; N, 14.32. C, 57.16; H, 6.48; N, 14.21. 1,4-Dihydro-N,N-dimethyl-3-propyl-4-methanesulfoniminoazet-2-amine (4f) Yellow oil; yield 0.13 g (57%). IR (KBr): νmax = 3436, 1518, 1269, 1142, 1086 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.86 (3 H, t, 3 J = 6.9 Hz, Me), 1.57–1.61 (2 H, m, CH2), 2.50 (2 H, t, 3 J = 6.9 Hz, CH2), 2.76 (3 H, s, Me), 2.90 (6 H, s, NMe2) 3.92 (1 H, s, NH). 13C NMR (125.7 MHz, CDCl3): δ = 13.8 (Me), 19.1 (CH2), 22.6 (CH2), 29.6 (Me), 40.5 (NMe2), 86.7 (C), 162.9 (C), 172.5 (C). MS (EI): m/z (%) = 231 (2) [M+], 187 (11), 161 (18), 119 (41), 79 (100), 43 (25). Anal. Calcd (%) for C9H17N3O2S (231.02): C, 46.73; H, 7.41; N, 18.17. Found: C, 47.02; H, 7.34; N, 18.08. 1,4-Dihydro-N,N-dimethyl-3-butyl-4-tosyliminoazet-2-amine (4g) Yellow oil; yield 0.20 g (62%). IR (KBr): νmax = 3452, 2933, 1520, 1401, 1270, 1118 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.85 (3 H, t, 3 J = 6.9 Hz, Me), 1.23–1.27 (2 H, m, CH2), 1.59–1.62 (2 H, m, CH2), 2.40 (3 H, s, Me), 2.50 (2 H, t, 3 J = 7.0 Hz, CH2), 2.85 (6 H, s, NMe2), 3.97 (1 H, s, NH), 7.38 (2 H, d, 3 J = 8.0 Hz, Ar), 7.92 (2 H, d, 3 J = 8.0 Hz, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 13.9 (Me), 19.4 (CH2), 22.4 (CH2), 27.3 (CH2), 30.4 (Me), 40.3 (NMe2), 86.6 (C), 125.6 (2 CH), 128.2 (2 CH), 137.7 (C), 141.2 (C), 166.0 (C), 172.5 (C). MS (EI): m/z (%) = 321 (3) [M+], 277 (16), 251 (13), 155 (100), 125 (20), 91 (51), 77 (41), 57 (52). Anal. Calcd (%) for C16H23N3O2S (321.00): C, 59.78; H, 7.21; N, 13.07. Found: C, 59.51; H, 7.27; N, 13.18. 1,4-Dihydro-N,N-dimethyl-3-butyl-4-benzenesulfoniminoazet-2-amine (4h) Yellow oil; yield 0.17 g (57%). IR (KBr): νmax = 3413, 2926, 1517, 1401, 1268, 1141, 1086 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.84 (3 H, t, 3 J = 6.9 Hz, Me), 1.24–1.28 (2 H, m, CH2), 1.59–1.62 (2 H, m, CH2), 2.49 (2 H, t, 3 J = 7.0 Hz, CH2), 2.92 (6 H, s, NMe2), 3.98 (1 H, s, NH), 7.26 (1 H, t, 3 J = 7.9 Hz, Ar), 7.39 (2 H, t, 3 J = 7.9 Hz, Ar), 7.80 (2 H, d, 3 J = 7.9 Hz, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 14.1 (Me), 20.0 (CH2), 22.5 (CH2), 27.3 (CH2), 40.5 (NMe2), 86.4 (C), 125.6 (CH), 128.7 (2 CH), 129.6 (2 CH), 138.6 (C), 167.3 (C), 172.5 (C). MS (EI): m/z (%) = 307 (3) [M+], 263 (12), 237 (10), 141 (100), 125 (29), 77 (35), 57 (50). Anal. Calcd (%) for C15H21N3O2S (307.00): C, 58.61; H, 6.89; N, 13.67. Found: C, 58.86; H, 6.74; N, 13.55. 1,4-Dihydro-N,N-dimethyl-3-butyl-4-methanesulfoniminoazet-2-amine (4i) Yellow oil; yield 0.13 g (53%). IR (KBr): νmax = 3513, 2934, 1521, 1403, 1270, 1118, 1042 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.85 (3 H, t, 3 J = 6.9 Hz, Me), 1.21–1.29 (2 H, m, CH2), 1.62–1.66 (2 H, m, CH2), 2.47 (2 H, t, 3 J = 7.0 Hz, CH2), 2.82 (3 H, s, Me), 2.90 (6 H, s, NMe2), 3.96 (1 H, s, NH). 13C NMR (125.7 MHz, CDCl3): δ = 14.0 (Me), 19.8 (CH2), 22.4 (CH2), 27.3 (CH2), 30.7 (Me), 40.4 (NMe2), 86.2 (C), 166.2 (C), 172.6 (C). MS (EI): m/z (%) = 245 (2) [M+], 201 (12), 175 (10), 125 (39), 79 (100), 57 (46). Anal. Calcd (%) for C10H19N3O2S (245.00): C, 48.95; H, 7.81; N, 17.13. Found: C, 48.76; H, 7.75; N, 17.04
  • 22 Recently, Sharpless and co-workers established anhydrous conditions with CuI in CHCl3/2,6-lutidine at 0 °C to prevent intermediate 6 from decomposing and provide selective formation of the desired 1-sulfonyltriazoles: Yoo EJ, Ahlquist M, Kim SH, Bae I, Fokin VV, Sharpless KB, Chang S. Angew. Chem. Int. Ed. 2007; 46: 1730
  • 23 Cassidy MP, Raushel J, Fokin VV. Angew. Chem. Int. Ed. 2006; 45: 3154
  • 24 Lu P, Wang Y. Synlett 2010; 165
  • 25 Yoo EJ, Ahlquist M, Bae I, Sharpless KB, Fokin VV, Chang S. J. Org. Chem. 2008; 73: 5520